Strengthening nucleic acid biosecurity screening against generative protein design tools

Advances in artificial intelligence (AI)-assisted protein engineering are enabling breakthroughs in the life sciences but also introduce new biosecurity challenges. Synthesis of nucleic acids is a choke point in AI-assisted protein engineering pipelines. Thus, an important focus for efforts to enhance biosecurity given AI-enabled capabilities is bolstering methods used by nucleic acid synthesis providers to screen orders. We evaluated the ability of open-source AI-powered protein design software to create variants of proteins of concern that could evade detection by the biosecurity screening tools used by nucleic acid synthesis providers, identifying a vulnerability where AI-redesigned sequences could not be detected reliably by current tools. In response, we developed and deployed patches, greatly improving detection rates of synthetic homologs more likely to retain wild type-like function.